Since the discovery of chlorpromazine (CPZ) in 1952, first-generation antipsychotics (FGAs)
have revolutionized psychiatric care in terms of facilitating discharge from hospital and …

There are significant differences between men and women in the efficacy and tolerability of
antipsychotic drugs. Here, we provide a comprehensive overview of what is currently known …

The Canadian Network for Mood and Anxiety Treatments (CANMAT) previously published
treatment guidelines for bipolar disorder in 2005, along with international commentaries and …

Lithium is an effective treatment in pregnancy and postpartum for the prevention of relapse
in bipolar disorder. However, lithium has also been associated with risks during pregnancy …

Objective: Uncertainty surrounds the risks of lithium use during pregnancy in women with
bipolar disorder. The authors sought to provide a critical appraisal of the evidence related to …

Background The pharmacoepidemiology of the long-term benefits and harms of medicines
in pregnancy and breastfeeding has received little attention. The impact of maternal …

The movement towards evidence-based practice in psychotherapy has recently provoked a
backlash. In the past few years, some authors have raised questions concerning the validity …

Background Breastfeeding women who are prescribed with psychotropic medications on a
regular basis are often concerned, regarding the possible implications of such treatment on …

This meta-analysis investigated the efficacy, safety, and tolerability of lamotrigine versus
placebo in preventing relapse and recurrence of mood episodes in women of childbearing …

Abstract Purpose of Review The aim of this paper is to evaluate recent literature on valproic
acid (VPA) in women and girls of childbearing age and to emphasize new findings. Recent …